G.A. Kennett - Concepedia

Author

G.A. Kennett

Also Known As

G A Kennett, G Kennett, G. A. KENNETT, G. A. Kennett, G. Kennett, G.A KENNETT, G.A Kennett, G.A. KENNETT, G.A. Kennett, GUY A. KENNETT

129

Publications

8.8K

Citations

H-Index

Concepts

All Affiliations

New Frontier Molecular Discovery (United Kingdom)National Hospital for Neurology and Neurosurgery University College London University of Sussex

About

G.A. Kennett is an author at New Frontier specializing in medicine, neuropharmacology, and pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	46	66	6.4K
2	Social Sciences	21	21	2.6K
3	Natural Sciences	8	8	414
4	Health Sciences	5	5	486
5	Public Health	1	1	43

G.A. Kennett

Publications

Citations

H-Index

Page 1

	Year	Citations
SB 242084, a Selective and Brain Penetrant 5-HT 2C Receptor Antagonist G.A. Kennett, Martyn Wood, Fiona Bright, Neuropharmacology Sb 242084Molecular PharmacologyFunctional SelectivityMedicineReceptor Antagonist	1997	523
Evidence that mCPP may have behavioural effects mediated by central 5‐HT<sub>1C</sub> receptors G.A. Kennett, G. Curzon British Journal of Pharmacology	1988	297
Female rats are more vulnerable than males in an animal model of depression: the possible role of serotonin G.A. Kennett, Francis Chaouloff, Margaret Marcou, Brain Research Stress HormonePsychiatryBehavioral NeuroscienceMood SymptomAnimal Model	1986	296
Anxiogenic-like effects of mCPP and TFMPP in animal models are opposed by 5-HT1C receptor antagonists G.A. Kennett, Peter S. Whitton, K. Shah, European Journal of Pharmacology Signal TransductionFunctional SelectivityMedicineImmunologyReceptor (Biochemistry)	1989	283
Evidence that hypophagia induced bymCPP and TFMPP requires 5-HT1C and 5-HT1B receptors; hypophagia induced by RU 24969 only requires 5-HT1B receptors G.A. Kennett, G. Curzon Psychopharmacology Molecular PharmacologyMolecular PhysiologySignal TransductionMedicinePhysiology	1988	253
Enhancement of some 5-HT-dependent behavioural responses following repeated immobilization in rats G.A. Kennett, Stephen L. Dickinson, G. Curzon Brain Research NeurophysiologyBehavioral NeuroscienceBehavioural PharmacologyPhysiologyRepeated Immobilization	1985	251
<i>In vitro</i>and<i>in vivo</i>profile of SB 206553, a potent 5‐HT<sub>2C</sub>/5‐HT<sub>2B</sub>receptor antagonist with anxiolytic‐like properties G.A. Kennett, Martyn Wood, Fiona Bright, British Journal of Pharmacology	1996	240
Pharmacological characterisation of the agonist radioligand binding site of 5-HT2A, 5-HT2B and 5-HT2C receptors Anil Kumar Misra, Kathleen Quirk, Karen Benwell, Naunyn-Schmiedeberg s Archives of Pharmacology Signal TransductionBiochemistryFunctional SelectivityMedicineAgonist Radioligand	2004	237
Antidepressant-like action of 5-HT1A agonists and conventional antidepressants in an animal model of depression G.A. Kennett, Colin T. Dourish, G. Curzon European Journal of Pharmacology 5-Ht1a AgonistsPsychiatryMedicinePsychotropic MedicationAnimal Model	1987	230
Preferential effects of the cannabinoid CB1 receptor antagonist, SR 141716, on food intake and body weight gain of obese (fa/fa) compared to lean Zucker rats S P Vickers, Lynn Webster, A. C. Wyatt, Psychopharmacology ObesityNutritionMetabolic SyndromeZucker RatsCannabis Use	2003	205

Page 1